Skip to main content

Academic Detailing Embraced as a Method to Combat Opioids in Northern California

Posted in News on 11.17.2017

Kasier Health News recently reported that money from Obama-era grants is being used to fund academic detailing programs in California for the purpose of educating providers on the risks of prescribing opioids. To date, academic detailing programs has been used to address overprescribing of opioids a...


Academic Detailing Conference Forges Connection, Ignites Action

Posted in Updates on 11.9.2017

Earlier this week members of the Alosa Health team attended the 5th International Conference on Academic Detailing, hosted by our friends and colleagues at NaRCAD. The conference is always an amazing opportunity to connect with others doing academic detailing work and to share insights and best prac...


Executive Director Testifies at Senate Committee Hearing

Posted in Updates on 10.25.2017

This week Alosa Health Executive Director Paul Fanikos testified at the Special Senate Committee Hearing on Health Care Cost Containment and Reform in support of investing in an evidence-based educational outreach program. During the testimony, Fanikos explained how a program focused on therapeutic ...


Alosa Founder Speaks at Innovation Meeting

Posted in Updates on 10.19.2017

Alosa Health founder, Dr. Jerry Avorn, was invited to speak at the Adriadne Labs health systems innovation meeting on October 12th. The focus of the dialog was on "Improving Physician Decision-Making at Scale: Alosa Health and the Academic Detailing Model". There was a lengthy question and answer pe...


Web-Based PrEP Resource Center Debuts in TN

Posted in Updates on 9.29.2017

Alosa Health partners at the Shelby County Department of Public Health unveiled a web-based resource for Tennessee residents who want to learn about PrEP, the FDA-approved HIV prevention medication. Visitors to the website, http://GetPRePTN.com/, can find a PrEP navigator, connect with a PrEP prescr...


Pharmaco-Epi Community Responds to New Study re: Cost of Cancer Drugs

Posted in News on 9.15.2017

Pin pointing the dollar amount that it actually costs to bring a drug to market is a tricky business. Until recently, the most widely accepted estimate has come from Tufts Center for the Study of Drug Development, at $2.7 billion per drug.  Yet a new study published in JAMA places that number ...


Dr. Choudry to Deliver Keynote at HIMSS Forum

Posted in Updates on 9.14.2017

Dr. Niteesh Choudry, Alosa Health physician advisor and professor at Harvard Medical School, as well as Executive Director at the Center for Healthcare Delivery Sciences, will deliver the keynote address at the upcoming Big Data and Healthcare Analytics Forum along with colleague Dr. John Quakenbush...


TOPCARE Intervention Shows Promise For Opioid Prescription Monitoring

Posted in Publications on 7.28.2017

A multicomponent intervention including academic detailing improved prescription opioid monitoring compared with electronic decision tools alone in a randomized trial of 4 urban safety-net primary care practices. JAMA Intern Med. Published online July 17, 2017. doi:10.1001/jamainternmed.2017.2468 ...


With Drug Resistance, Prevention and Early Detection is Key

Posted in News on 7.13.2017

A news release from the World Health Organization (WHO) stated that gonorrhea bacteria are evolving in a way that makes the infection much harder to treat. Gonorrhea is a sexually transmitted infection (STI) that is generally curable with antibiotics. However, new data from various countries around ...


Post Editorial Reflects on Progress in HIV/AIDs Treatment and Prevention

Posted in News on 7.12.2017

The Washington DC Department of Health HIV/AIDS, Hepatitis, STD, and TB Administration (HAHSTA) recently published its Annual Epidemiology & Surveillance Report with good news, as noted by the editorial staff of the Washington Post. The report shows substantial progress being made in the D.C. a...